Skip to content
Clinical Trials – home

Human Plasma Proteins with Not Less Than 96% Albumin: A Comprehensive Guide for Patients

2 / 2
trials open to patients / all trials
2+
Countries

In short

This article discusses two clinical trials investigating the use of human albumin solutions in different medical contexts. The first trial focuses on patients with decompensated cirrhosis, examining the safety and efficacy of a restored structural profile albumin solution. The second trial explores how albumin levels affect the pharmacokinetics of cefazolin in cardiac surgery patients. Both studies aim to improve patient outcomes and enhance our understanding of albumin's role in various medical conditions.

What is Albumin?

Human plasma proteins with not less than 96% albumin, often simply referred to as albumin, is a medication derived from human blood plasma. Albumin is the most abundant protein in human blood and plays crucial roles in maintaining health.

Albumin has several important functions in the body:

  • It helps maintain proper fluid balance in your blood vessels and tissues
  • It transports various substances throughout your body, including hormones, vitamins, and medications
  • It helps maintain blood pressure
  • It acts as an antioxidant, protecting your body from harmful substances

Medical Uses of Albumin

Albumin is used to treat various medical conditions, particularly those involving low blood volume or low albumin levels in the blood. Some common uses include:

  • Hypovolemia: A condition where there's not enough blood circulating in your body
  • Hypoalbuminemia: Low levels of albumin in the blood, which can occur in various diseases
  • Liver disease: Particularly in cases of severe cirrhosis
  • Burns: To help replace lost fluids and proteins
  • Shock: To help restore blood volume
  • Certain types of surgery: To maintain proper fluid balance

Albumin in Decompensated Cirrhosis

One area where albumin is being extensively studied is in the treatment of decompensated cirrhosis. This is an advanced stage of liver disease where the liver can no longer function properly.

In decompensated cirrhosis, albumin is used to:

  • Treat ascites (fluid buildup in the abdomen)
  • Prevent complications after removal of ascites fluid (paracentesis)
  • Improve overall liver and kidney function
  • Potentially reduce the risk of infections and other complications

Researchers are currently investigating a new form of albumin called reHA (restored Human Albumin) that may be more effective in treating decompensated cirrhosis.

Albumin in Cardiac Surgery

Albumin also plays a role in cardiac (heart) surgery. It's sometimes used as part of the solution that primes the heart-lung machine used during open-heart surgeries.

Additionally, albumin levels can affect how certain medications, like antibiotics, work in the body. Researchers are studying how different albumin levels might impact the effectiveness of antibiotics given during cardiac surgery.

How is Albumin Administered?

Albumin is typically given as an intravenous (IV) infusion, which means it's delivered directly into your bloodstream through a vein. The dose and frequency of administration depend on your specific condition and needs.

For example:

  • In cirrhosis treatment, doses might range from 20 to 80 grams, given weekly or biweekly
  • In cardiac surgery, smaller doses of about 6 grams might be used

Safety and Side Effects

Albumin is generally considered safe, as it's a natural component of human blood. However, like all medications, it can have side effects. These may include:

  • Allergic reactions (rare)
  • Fever
  • Chills
  • Nausea
  • Vomiting

Your doctor will carefully monitor you during and after albumin administration to ensure your safety.

Ongoing Research

Researchers are continually studying albumin to better understand its effects and potential uses. Current areas of research include:

  1. Restored Human Albumin (reHA): This is a new form of albumin that may be more effective in treating decompensated cirrhosis. Researchers are comparing it to standard albumin solutions to see if it can improve liver function and reduce complications more effectively.
  2. Albumin and Antibiotic Effectiveness: Studies are looking at how albumin levels in the body might affect how well certain antibiotics work, particularly in patients undergoing cardiac surgery.
  3. Long-term Albumin Treatment: Researchers are investigating the benefits and safety of long-term albumin treatment in patients with cirrhosis.

These ongoing studies aim to improve our understanding of albumin and potentially expand its uses in medicine.

Questions people often ask

Conditions where Human Plasma Proteins With Not Less Than 96% Albumin is being studied

Each condition opens its own overview and trial list

Trials with Human Plasma Proteins With Not Less Than 96% Albumin

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).